AI-powered pathology tools
Open for applications
AI-powered pathology tools
201-500 employees
Open for applications
201-500 employees
To improve patient outcomes with AI-powered pathology.
PathAI is a leader in the field of AI-powered pathology, dedicated to transforming patient outcomes by harnessing the power of AI. Its core mission revolves around enhancing the accuracy of diagnoses and the effectiveness of disease treatments, particularly in critical areas like cancer.
PathAI's pioneering spirit is evident through its breakthroughs, exemplified by innovations such as the AIM-HER2 Breast Cancer algorithm. This tool automates HER2 scoring and introduces a novel approach with additive multiple instance learning (aMIL) heatmaps, offering insights into scoring mechanisms. Additionally, PathAI's PathExplore panel of human interpretable features (HIFs) fosters collaborative research, thus enhancing understanding of the tumor microenvironment.
As the company moves forward, it is poised to continue shaping the landscape of AI-powered pathology, driving advancements in medical research, diagnostics, and drug development, while upholding its central mission to improve patient well-being.
Steph
Company Specialist at Welcome to the Jungle
May 2021
$165m
SERIES C
Nov 2019
$15m
SERIES B
West Fens, Boston, MA
Andrew Beck
(CEO)Graduated from Stanford University with a PhD in Biomedical Informatics. Previously worked at Harvard Medical School as a Professor of Pathology.
Aditya Khosla
(Advisor)Graduated from the Massachusetts Institute of Technology with a PhD in Computer Science. They now serve as the CTO at Iterative Health.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 1 more job at PathAI